相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
Yang Xu et al.
AMERICAN HEART JOURNAL (2022)
Ambulatory Treatments for RAAS Inhibitor-Related Hyperkalemia and the 1-Year Risk of Recurrence
Gregory L. Hundemer et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)
Barriers to ACEI/ARB Use in Proteinuric Chronic Kidney Disease: An Observational Study
Ian E. McCoy et al.
MAYO CLINIC PROCEEDINGS (2021)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
Current treatment and unmet needs of hyperkalaemia in the emergency department
Zubaid Rafique et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2019)
Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States
Daniel P. Murphy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Hyperkalemia: pathophysiology, risk factors and consequences
Robert W. Hunter et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom
Cecilia Linde et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Acute Increases in Serum Creatinine After Starting Angiotensin-Converting Enzyme Inhibitor-Based Therapy and Effects of its Continuation on Major Clinical Outcomes in Type 2 Diabetes Mellitus: The ADVANCE Trial
Toshiaki Ohkuma et al.
HYPERTENSION (2019)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Hyperkalemia constitutes a constraint for implementing renin-angiotensin-aldosterone inhibition: the widening gap between mandated treatment guidelines and the real-world clinical arena
Murray Epstein
KIDNEY INTERNATIONAL SUPPLEMENTS (2016)
Management of Hyperkalemia: An Update for the Internist
Csaba P. Kovesdy
AMERICAN JOURNAL OF MEDICINE (2015)
Underprescription of Renin-Angiotensin System Blockers in Moderate to Severe Chronic Kidney Disease
Shayan Shirazian et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2015)
The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: Results from the ONTARGET trial
Hiddo J. Lambers Heerspink et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)
Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial
Y. Miao et al.
DIABETOLOGIA (2011)
Importance of Blood Pressure Lowering in Type 2 Diabetes: Focus on ADVANCE
John Chalmers et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2010)
A New Equation to Estimate Glomerular Filtration Rate
Andrew S. Levey et al.
ANNALS OF INTERNAL MEDICINE (2009)
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
Anushka Patel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial
A. Patel et al.
LANCET (2007)
分享论文
